Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis
Joint Authors
Hamid, Ban Hadi
Ali, Ahmad Subayh Abd
Saghir, Halah Abd al-Ghani
Source
al-Kindy College Medical Journal
Issue
Vol. 14, Issue 1 (30 Jun. 2018), pp.4-7, 4 p.
Publisher
University of Baghdad al-Kindi College of Medicine
Publication Date
2018-06-30
Country of Publication
Iraq
No. of Pages
4
Main Subjects
Abstract EN
Background: Osteoporosis is a skeletal defect manifested by a reduction of bone strength as a result of reduced bone mass to the extent that there is a higher risk of fracture even on minor trauma.
Hysterectomy in a premenopausal woman is a well known cause of ovarian failure resulting in an increased risk of osteoporosis.
Objective : To clarify bisphosphonate's preventive effect on osteopenia and osteoporosis in premenopausal women after hysterectomy.
Type of the study: Cross –sectional study.
Method: 84 premenopausal females post hysterectomy aged between 40 – 50 years, were enrolled in this randomized controlled double blinded trail at Al Yarmouk teaching hospital and private clinic in Baghdad for a period of two years from Augest 2011 till July 2013.
Participants were assigned as: 1stgroup (study group 42 women): received risedronate treatment "over a period of one year" with calcium and vitamin D; and 2ndgroup (control group 42 women) were taken as a matched group for:"age, body mass index (BMI) and fracture history", received only calcium and vitamin D as a placebo.
Bone density had been assayed at the end of the year for all participants and evaluated for osteopenia and osteoporosis.
Results: Osteopenia and osteoporosis were significantly lower in the risedronate arm as compared to those not received the drug "14.3% & 11.9% versus 26.1% & 19% respectively".
Conclusion: The bone mineral density results were significantly better in those who received risedronate than those not received the drug.
American Psychological Association (APA)
Hamid, Ban Hadi& Ali, Ahmad Subayh Abd& Saghir, Halah Abd al-Ghani. 2018. Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis. al-Kindy College Medical Journal،Vol. 14, no. 1, pp.4-7.
https://search.emarefa.net/detail/BIM-840155
Modern Language Association (MLA)
Hamid, Ban Hadi…[et al.]. Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis. al-Kindy College Medical Journal Vol. 14, no. 1 (2018), pp.4-7.
https://search.emarefa.net/detail/BIM-840155
American Medical Association (AMA)
Hamid, Ban Hadi& Ali, Ahmad Subayh Abd& Saghir, Halah Abd al-Ghani. Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis. al-Kindy College Medical Journal. 2018. Vol. 14, no. 1, pp.4-7.
https://search.emarefa.net/detail/BIM-840155
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 6-7
Record ID
BIM-840155